Elanco Animal Health Incorporated · ELAN · Next earnings

Elanco Animal Health Incorporated reports Friday, Nov 6, 2026

ELAN reports before market open with consensus EPS at $0.20 and revenue at $1.21B. Last quarter: Elanco lifts 2026 outlook as innovation products drive Q3 growth

Reports Before market open0 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.20 Calendar consensus
Consensus revenue $1.21B Calendar consensus
Report date Nov 6, 2026 Friday, date estimated
Session Before market open 0 days away

Where ELAN left off: FY2026 Q3

Full report

Elanco lifts 2026 outlook as innovation products drive Q3 growth

EPS surprise — Reported — vs $0.20
Revenue surprise — Reported — vs $1.21B
Stock move +6.2% Event window
Subsequent drift 0.0% Up to 20 sessions

Raised full-year outlook: about 8% organic revenue growth, adjusted EBITDA growth of 17% at the midpoint and adjusted EPS of $1.17–$1.20. The prior quarter's organic revenue growth outlook was 6–7%.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Competitive pressure and promotional activity may affect sales timing and market share.
  • Costco's non-renewal and related inventory drawdowns may weigh on near-term revenue.
  • Regional farm-animal cycles, including dairy and swine, may create volatility.
  • Execution on product launches and European rollout remains important; inflation-related inventory costs and ProFenta mix may pressure margins.

Questions analysts left open

  • Whether gross-margin expansion can be sustained and when further margin improvements will occur.
  • The effect of Costco's non-renewal on retail sales and guidance.
  • Competitive dynamics in the JAK market and broader pet-health market.
  • Execution of Befrena's full launch and Credelio Quattro's European rollout.
  • Potential volatility from regional dairy, swine and poultry cycles.

Ask FN2 about ELAN next report

Choose a question to continue your research

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Get the ELAN recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent ELAN quarters

All ELAN earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.